Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precisi...
Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for hi...
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potent...
